Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v6-EN
Language French English
Date Updated 2020-03-05 2020-01-09
Drug Identification Number 02441160 02441160
Brand name ACT TEMOZOLOMIDE ACT TEMOZOLOMIDE
Common or Proper name TEMOZOLOMIDE CAPS TEMOZOLOMIDE CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TEMOZOLOMIDE TEMOZOLOMIDE
Strength(s) 5MG 5MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 5 5
ATC code L01AX L01AX
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-31 2019-10-31
Estimated end date 2020-03-31 2020-02-29
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments